Top

Published in:

Open Access 08-03-2024 | Breast Cancer | Research

Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients

Authors: Mürsel Şahin, Seher Nazlı Kazaz, Fatih Kartaler, Burcu Kodal, Seda Altuntaş, Elif Yüce, Oğuzhan Ekrem Turan, Merih Kutlu

Published in: Cardiovascular Toxicology | Issue 4/2024

Abstract

Cancer therapy-related cardiac dysfunction (CTRCD) is still a serious problem. Existing risk scores are insufficient for risk classification, especially in low and medium-risk patients. This study aims to evaluate if arterial stiffness (AS) measurement, which is associated with most of the known risk factors, can be a useful parameter for predicting subsequent CTRCD in patients with breast cancer (BC). Patients with BC were included in the study. All patients’ AS parameters such as pulse wave velocity (PWV), augmentation index (AIx), augmentation pressure (AP), and echocardiographic parameters were obtained before treatment. During treatment, echocardiographic follow-up with routine parameters and left ventricle global longitudinal strain (LVGLS) were measured. Patients were evaluated on whether CTRCD occurred or not. A total of 67 patients were analyzed. The mean age of the study population was 54.9 ± 11 years. Baseline characteristics were similar except for age. No CTRCD diagnosis was obtained according to left ventricle ejection fraction (LVEF) reduction, but 18 patients (26.8%) developed CTRCD regarding the decline in LVGLS. Left ventricle hypertrophy and diastolic dysfunction were more frequent in patients with CTRCD (p = 0.016 and p = 0.015, respectively). PWV, AIx, and AP as AS parameters were significantly higher in patients with CTRCD, but Alx@75 were not (p = 0.005, p = 0.034, p = 0.008, p = 0.077, respectively). A positive correlation between PWV and a decreased percent in LVGS (R = 0.607, p < 0.001) was observed. ROC curve analyses revealed an AUC of 0.747 (p = 0.02, 95% CI 0.632–0.832) for PWV. A PWV value of 9.2 m/s predicted CTRCD with 94% sensitivity and 73% specificity. AS measurement may be useful for predicting CTRCD in patients with low to medium-risk BC.

Graphical Abstract

Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, ... ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229–4361. https://doi.org/10.1093/eurheartj/ehac244

Gronewold, J., Kropp, R., Lehmann, N., Stang, A., Mahabadi, A. A., Kälsch, H., Weimar, C., Dichgans, M., Budde, T., Moebus, S., Jöckel, K. H., Erbel, R., & Hermann, D. M. (2019). Cardiovascular risk and atherosclerosis progression in hypertensive persons treated to blood pressure targets. Hypertension, 74(6), 1436–1447. https://doi.org/10.1161/HYPERTENSIONAHA.119.13827CrossRefPubMed

Tini, G., Sarocchi, M., Ameri, P., Arboscello, E., & Spallarossa, P. (2019). The need for cardiovascular risk factor prevention in cardio-oncology. JACC Heart Failure, 7, 367–368. https://doi.org/10.1016/j.jchf.2019.01.002CrossRefPubMed

Lyon, A. R., Dent, S., Stanway, S., Earl, H., Brezden-Masley, C., Cohen-Solal, A., Tocchetti, C. G., Moslehi, J. J., Groarke, J. D., Bergler-Klein, J., Khoo, V., Tan, L. L., Anker, M. S., von Haehling, S., Maack, C., Pudil, R., Barac, A., Thavendiranathan, P., Ky, B., ... Lenihan, D. (2020). Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: A position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. European Journal of Heart Failure, 22(11), 1945–1960. https://doi.org/10.1002/ejhf.1920

Law, W., Johnson, C., Rushton, M., & Dent, S. (2017). The Framingham risk score underestimates the risk of cardiovascular events in the HER2-positive breast cancer population. Current Oncology, 24(5), e348–e353. https://doi.org/10.3747/co.24.3684CrossRefPubMedPubMedCentral

Suntheralingam, S., Fan, C. S., Calvillo-Argüelles, O., Abdel-Qadir, H., Amir, E., & Thavendiranathan, P. (2022). Evaluation of risk prediction models to ıdentify cancer therapeutics related cardiac dysfunction in women with HER2+ breast cancer. Journal of Clinical Medicine, 11(3), 847. https://doi.org/10.3390/jcm11030847CrossRefPubMedPubMedCentral

Mitchell, G. F., Hwang, S.-J., Vasan, R. S., Larson, M. G., Pencina, M. J., Hamburg, N. M., Vita, J. A., Levy, D., & Benjamin, E. J. (2010). Arterial stiffness and cardiovascular events: The framingham heart study. Circulation, 121, 505–511. https://doi.org/10.1161/CIRCULATIONAHA.109.886655CrossRefPubMedPubMedCentral

Willum-Hansen, T., Staessen, J. A., Torp-Pedersen, C., Rasmussen, S., Thijs, L., Ibsen, H., & Jeppesen, J. (2006). Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation, 113, 664–670. https://doi.org/10.1161/CIRCULATIONAHA.105.579342CrossRefPubMed

Bonarjee, V. V. S. (2018). Arterial stiffness: A prognostic marker in coronary heart disease. Available methods and clinical application. Frontiers in Cardiovascular Medicine, 5, 64. https://doi.org/10.3389/fcvm.2018.00064CrossRefPubMedPubMedCentral

10.

Angoff, R., Mosarla, R. C., & Tsao, C. W. (2021). Aortic stiffness: Epidemiology, risk factors, and relevant biomarkers. Frontiers in Cardiovascular Medicine, 8(8), 709396. https://doi.org/10.3389/fcvm.2021.709396CrossRefPubMedPubMedCentral

11.

Van Bortel, L. M., Laurent, S., Boutouyrie, P., Chowienczyk, P., Cruickshank, J. K., De Backer, T., Filipovsky, J., Huybrechts, S., Mattace-Raso, F. U., Protogerou, A. D., Schillaci, G., Segers, P., Vermeersch, S., Artery Society, European Society of Hypertension Working Group on Vascular Structure and Function, European Network for Noninvasive Investigation of Large Arteries. (2012). Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. Journal of Hypertension, 30, 445–448. https://doi.org/10.1097/HJH.0b013e32834fa8b0CrossRefPubMed

12.

Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., & European Network for Non-invasive Investigation of Large Arteries. (2006). Expert consensus document on arterial stiff ness: Methodological issues and clinical applications. European Heart Journal, 27, 2588–2605.CrossRefPubMed

13.

Pauca, A. L., O’Rourke, M. F., & Kon, N. D. (2001). Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension, 38, 932–937.CrossRefPubMed

14.

Townsend, R. R., Wilkinson, I. B., Schiffrin, E. L., Avolio, A. P., Chirinos, J. A., Cockcroft, J. R., Heffernan, K. S., Lakatta, E. G., McEniery, C. M., Mitchell, G. F., Najjar, S. S., Nichols, W. W., Urbina, E. M., Weber, T., American Heart Association Council on Hypertension. (2015). Recommendations for improving and standardizing vascular research on arterial stiffness: A scientific statement from the American Heart Association. Hypertension, 66(3), 698–722. https://doi.org/10.1161/HYP.0000000000000033CrossRefPubMed

15.

Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., Patel, A., DeCara, J., Mitchell, J., Harrison, E., Moslehi, J., Witteles, R., Calabro, M. G., Orecchia, R., de Azambuja, E., ... ESMO Guidelines Committee (2020). Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Annals of Oncology, 31(2), 171–190. https://doi.org/10.1016/j.annonc.2019.10.023

16.

Sarafidis, P. A., Loutradis, C., Karpetas, A., Tzanis, G., Piperidou, A., Koutroumpas, G., Raptis, V., Syrgkanis, C., Liakopoulos, V., Efstratiadis, G., London, G., & Zoccali, C. (2017). Ambulatory pulse wave velocity is a stronger predictor of cardiovascular events and all-cause mortality than office and ambulatory blood pressure in hemodialysis patients. Hypertension, 70, 148–157. https://doi.org/10.1161/HYPERTENSIONAHA.117.09023CrossRefPubMed

17.

Redheuil, A., Wu, C., Kachenoura, N., Ohyama, Y., Yan, R., Bertoni, A., Hundley, G. W., Duprez, D., Jacobs, D., Daniels, L., Darwin, C., Sibley, C., Bluemke, D., & Lima, J. (2014). Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: The MESA study. Journal of the American College of Cardiology, 64, 2619–2629. https://doi.org/10.1016/j.jacc.2014.09.060CrossRefPubMedPubMedCentral

18.

Vlachopoulos, C., Aznaouridis, K., & Stefanadis, C. (2010). Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. Journal of the American College of Cardiology, 55, 1318–1327. https://doi.org/10.1016/j.jacc.2009.10.061CrossRefPubMed

19.

Townsend, R., Wilkinson, I., Schiffrin, E., Avolio, A., Chirinos, J., Cockcroft, J., Heffernan, K., Lakatta, E., McEniery, C., Mitchell, G., Najjar, S., Nichols, W., Urbina, E., & Weber, T. (2015). Recommendations for improving and standardizing vascular research on arterial stiffness: A scientific statement from the American Heart Association. Hypertension, 66, 698–722. https://doi.org/10.1161/HYP.0000000000000033CrossRefPubMed

20.

Lakatta, E. G., & Levy, D. (2003). Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Circulation, 107, 139–146. https://doi.org/10.1161/01.CIR.0000048892.83521.58CrossRefPubMed

21.

Kruszyńska, E., Ciecierzyńska, B., Dziuba, M., Dudek, K., Uchmanowicz, I., & Łoboz-Grudzień, K. (2013). Relationship between vascular age and classic cardiovascular risk factors and arterial stiffness. Cardiology Journal, 20, 394–401. https://doi.org/10.5603/CJ.2013.0098CrossRefPubMed

22.

Mitchell, G. F. (2014). Arterial stiffness and hypertension: Chicken or egg? Hypertension, 64, 210–214. https://doi.org/10.1161/HYPERTENSIONAHA.114.03449CrossRefPubMed

23.

Kaess, B. M., Rong, J., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, D., Benjamin, E. J., Vasan, R. S., & Mitchell, G. F. (2012). Aortic stiffness, blood pressure progression, incident hypertension. JAMA, 308, 875–881. https://doi.org/10.1001/2012.jama.10503CrossRefPubMedPubMedCentral

24.

Mansia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A., Zanchetti, A., ... European Society of Hypertension; European Society of Cardiology. (2007). 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Journal of Hypertension, 25, 1105–1187. https://doi.org/10.1097/HJH.0b013e3281fc975a

25.

Bowles, E. J., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A. B., Davis, R. L., Habel, L. A., Yood, M. U., McCarty, C., Magid, D. J., Wagner, E. H., Pharmacovigilance Study Team. (2012). Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: A retrospective cohort study. Journal of the National Cancer Institute, 2012(104), 1293–1305.CrossRef

26.

Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., Fiorentini, C., & Cipolla, C. M. (2015). Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation, 131(22), 1981–1988. https://doi.org/10.1161/CIRCULATIONAHA.114.013777CrossRefPubMed

27.

Townsend, R. R., Wilkinson, I. B., Schiffrin, E. L., Avolio, A. P., Chirinos, J. A., Cockcroft, J. R., Heffernan, K. S., Lakatta, E. G., McEniery, C. M., Mitchell, G. F., Najjar, S. S., Nichols, W. W., Urbina, E. M., Weber, T., American Heart Association. (2015). Recommendations for improving and standardizing vascular research on arterial stiffness: A scientific statement from the American Heart Association. Hypertension, 66(3), 698–722. https://doi.org/10.1161/HYP.0000000000000033CrossRefPubMed

28.

Chantler, P. D., Lakatta, E. G., & Najjar, S. S. (2008). Arterial-ventricular coupling: Mechanistic insights into cardiovascular performance at rest and during exercise. Journal of Applied Physiology (1985), 105(4), 1342–1351. https://doi.org/10.1152/japplphysiol.90600.2008. Erratum in: Journal of Applied Physiology (2009), 106(3), 1027.

29.

Sonaglioni, A., Baravelli, M., Lombardo, M., Sommese, C., Anzà, C., Kirk, J. A., & Padeletti, L. (2018). Ventricular-arterial coupling in centenarians without cardiovascular diseases. Aging Clinical and Experimental Research, 30(4), 367–373. https://doi.org/10.1007/s40520-017-0783-yCrossRefPubMed

Title: Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients
Authors: Mürsel Şahin
Seher Nazlı Kazaz
Fatih Kartaler
Burcu Kodal
Seda Altuntaş
Elif Yüce
Oğuzhan Ekrem Turan
Merih Kutlu
Publication date: 08-03-2024
Publisher: Springer US
Keywords: Breast Cancer
Breast Cancer
Cancer Therapy
Published in: Cardiovascular Toxicology / Issue 4/2024
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-024-09841-w

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients

Abstract

Graphical Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Graphical Abstract

Please log in to get access to this content

Other articles of this Issue 4/2024

Subacute Exposure to Gaseous Pollutants from Diesel Engine Exhaust Attenuates Capsaicin-Induced Cardio-Pulmonary Reflex Responses Involving Oxidant Stress Mechanisms in Adult Wistar Rats

Correlation Between Blood Cadmium Levels and Platelet Characteristics, As Well As Their Impact on Susceptibility to Coronary Heart Disease: Findings from NHANES 2005–2018 Data

Association Between Cancer and Cardiovascular Toxicity: A Nationwide Cross-Sectional Study on NHANES 1999–2018

BMSCs-derived Exosome CISH Alleviates Myocardial Infarction by Inactivating the NF-κB Pathway to Stimulate Macrophage M2 Polarization

Effects of Halloysite Nanotubes and Multi-walled Carbon Nanotubes on Kruppel-like Factor 15-Mediated Downstream Events in Mouse Hearts After Intravenous Injection

Genetically Predicted Apolipoprotein E Levels with the Risk of Panvascular Diseases: A Mendelian Randomization Study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page